Evolution of the Average Target: AstraZeneca PLC

Evolution of the Average Target - AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Evolution of the Target Price - AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

6c9a.49Q5TY81vfDB9GVO-jDvhU4_4Vm4O1CuniSWBSyiPek.0pdAAOtfhbOEsAcAu1qLwTsHtwHBTAL-x2XyTE_VRdqutmY-ykPQg5GxPA~fceac42d00d9ae167a3f9148b66bf0d2
21/10 AstraZeneca PLC : Gets a Buy rating from JP Morgan ZD
20/10 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
16/10 AstraZeneca PLC : Berenberg remains its Buy rating ZD
15/10 RBC Reaffirms AstraZeneca's Outperform Rating Ahead of Q3 Results MT
15/10 AstraZeneca PLC : UBS gives a Buy rating ZD
15/10 AstraZeneca PLC : Gets a Buy rating from RBC ZD
14/10 AstraZeneca PLC : Deutsche Bank reiterates its Neutral rating ZD
07/10 Berenberg Trims AstraZeneca PT, Affirms Outperform Rating MT
07/10 Deutsche Bank ups Glencore, BHP price targets AN
07/10 AstraZeneca PLC : Buy rating from Berenberg ZD
07/10 AstraZeneca PLC : Jefferies gives a Buy rating ZD
07/10 AstraZeneca PLC : Bernstein reaffirms its Buy rating ZD
06/10 Genmab in Good Health, Schneider Lacks Energy Zonebourse
06/10 BofA Forecasts 'In-line' Q3, Unchanged FY26 Outlook for AstraZeneca Amid Oncology Momentum MT
30/09 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
30/09 AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says MT
29/09 Stocks Defy the Pressure Zonebourse
29/09 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
29/09 AstraZeneca PLC : RBC reaffirms its Buy rating ZD
29/09 AstraZeneca PLC : JP Morgan maintains a Buy rating ZD
29/09 AstraZeneca PLC : Deutsche Bank is Neutral ZD
18/09 Berenberg and Deutsche say buy Bytes Technology AN
16/09 AstraZeneca PLC : Gets a Buy rating from UBS ZD
16/09 Oddo BHF cuts Safestore to neutral, cuts target AN
16/09 AstraZeneca PLC : Buy rating from Jefferies ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+22.47%
+4.56%
+5.91%
-0.3%
-1.29%
+9.97%
-3.4%
-9.69%
+2.66%
+14.58%
Average +4.55%
Weighted average by Cap. +4.21%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
171.54USD
Average target price
210.12USD
Spread / Average Target
+22.49%
High Price Target
262.96USD
Spread / Highest target
+53.30%
Low Price Target
154.83USD
Spread / Lowest Target
-9.74%

Analyst Consensus Detail

Analyst consensus - AstraZeneca PLC

Consensus revision (last 18 months)

Consensus revision (last 18 months) - AstraZeneca PLC
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AstraZeneca PLC
  1. Stock Market
  2. Stocks
  3. AZN Stock
  4. Consensus AstraZeneca PLC